# Task V30: GMP Manufacturing of WNV Vaccine

> **NIH NIH N01** · ADVANCED BIOSCIENCE LABORATORIES, INC. · 2022 · $1,730,516

## Abstract

The Manufacture and Characterization Services (MCS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services spanning product development planning and feasibility assessments; product development and cGMP compliant manufacture for Phase I/II clinical studies; toxicology studies; technical and facility audits; and regulatory support appropriate for submission to the U.S. Food and Drug Administration (FDA).  These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism and emerging and re-emerging infectious diseases.  This contract also provides for manufacture of challenge material.

## Key facts

- **NIH application ID:** 10703294
- **Project number:** 272201800009I-0-759302200001-1
- **Recipient organization:** ADVANCED BIOSCIENCE LABORATORIES, INC.
- **Principal Investigator:** WANG HONG
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,730,516
- **Award type:** —
- **Project period:** 2018-05-15 → 2028-05-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10703294

## Citation

> US National Institutes of Health, RePORTER application 10703294, Task V30: GMP Manufacturing of WNV Vaccine (272201800009I-0-759302200001-1). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10703294. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*